About IBT

Founded in 1995, Immune Balance Technologies (IBT) develops technologies to modulate the human immune system, to treat disease, preserve wellness and reverse the aging process. The company’s platform to achieve its objective applies to all viral diseases, cancer, autoimmune disease, allergies, wellness and aging.

Over the last twenty years one of the company’s founders, Dr. Robert H. Keller, has been involved in scientific research in both Immunology and Hematology. Dr. Keller also treats patients with immune dysfunction through his medical practice The KBK Institute, a state of the art medical clinic for the cutting edge treatment of patients afflicted with chronic illnesses including HIV, Hemophilia, Hepatitis, Chronic Fatigue Syndrome, Autoimmune diseases, pre and post Cancer care, chronic neurogenerative diseases and aging – which we view as a disease.

Research efforts at IBT can be divided into four separate, but overlapping areas:

The first deals with HIV and stems from the fact that tens of millions of patients worldwide have been infected, yet only a small percentage can afford the currently effective HAART therapy. IBT developed a novel, immuno-theraputic which is impervious to viral mutation. This technology has been transferred to Phoenix BioSciences, Inc., a subsidiary of IBT, and has the potential to become the standard of care in HIV worldwide.

Another area deals with Hepatitis C which affects approximately 200-250 million people worldwide. Since both HIV and Hepatitis C are RNA retroviruses and show similar viral kinetics, we have also begun studies to determine if an immuno-theraputic agent could function to thwart HCV as we have shown for HIV. One significant difficulty in this regard was the lack of an invitro culture system to adequately evaluate potential anti-HCV therapeutic agents.
 
To that end, IBT’s first goal has been to develop such an invitro system. Proof of concept studies have been completed and such an invitro culture system has been initiated. In addition, studies are ongoing using another immunodulatory agent, which may treat Alzheimer’s and Parkinson’s.

Further research efforts at IBT lead to the development of a complex Glutathione supplement – the most powerful, prevalent antioxidant in the human body. After successfully developing a novel diagnostic test to measure glutathione and confirming decreased glutathione levels in the majority of his patients, Dr. Keller developed and patented a nutritional supplement designed specifically to produce and preserve existing stores of glutathione. More nutritional developments have occurred due to other issues Dr. Keller has identified in his patients, and as a result, VitImmune, a nutraceutical company with a line of products geared towards enhancing the immune system and slowing the biological clock, was formed in 1997. These products are designed to address problems in patients suffering from a variety of Immune and degenerative diseases and protect the health and youth of those not yet afflicted by illness and who live in an increasingly polluted environment and are under constant stress. Unlike other nutritional companies, all of VitImmune’s products undergo extensive clinical testing before being offered to the patients and the public. VitImmune represents Dr. Keller’s belief in maintaining wellness as well as treating illness.

[Back to Top]